What Is NIPT and Should I Have It? A Guide for London Mums
What Is NIPT and Should I Have It? A Guide for London Mums
Published
Tags
Non-invasive prenatal testing (NIPT) has revolutionised prenatal screening since its introduction to the UK in 2012, offering expectant mothers a safe and highly accurate way to screen for chromosomal conditions. With the NHS now incorporating NIPT into its screening programme for high-risk pregnancies, many London mums are asking themselves whether this advanced genetic test is right for them. Understanding what NIPT involves and its benefits can help you make an informed decision about your prenatal care.
What Is NIPT?
Non-invasive prenatal testing (NIPT), also known as cell-free DNA screening, is a blood test that analyses fragments of fetal DNA circulating in the mother’s bloodstream. This cutting-edge technology can detect chromosomal abnormalities such as Down’s syndrome (trisomy 21), Edwards’ syndrome (trisomy 18), and Patau’s syndrome (trisomy 13) with remarkable accuracy.
Unlike traditional screening methods that combine blood tests with ultrasound measurements, NIPT screening analyses actual genetic material from the developing baby. This makes it significantly more accurate than conventional screening tests, with detection rates exceeding 99% for Down’s syndrome.
The test is completely safe for both mother and baby, requiring only a simple blood draw from the mother’s arm. There’s no risk of miscarriage, unlike invasive diagnostic tests such as amniocentesis or chorionic villus sampling (CVS).
How Does NIPT Work?
During pregnancy, small fragments of DNA from the placenta circulate freely in the mother’s bloodstream. Since the placenta and baby share the same genetic makeup in the vast majority of cases, this cell-free DNA provides a window into the baby’s chromosomal composition.
The blood sample is sent to a specialised laboratory where sophisticated technology extracts and analyses this fetal DNA. The laboratory examines the chromosomes for any numerical abnormalities that could indicate conditions such as trisomy 21, 18, or 13.
Advanced NIPT tests can also screen for sex chromosome abnormalities, microdeletions, and even determine the baby’s sex. Some comprehensive screening options, such as those offered through genetic testing services, can analyse hundreds of genetic conditions.
When Can NIPT Be Performed?
NIPT can be performed from as early as 9-10 weeks of pregnancy, making it one of the earliest screening options available. This timing allows sufficient fetal DNA to be present in the mother’s bloodstream for accurate analysis.
The early timing of NIPT offers several advantages:
- Early reassurance: Results are typically available within 7-10 working days, providing peace of mind early in pregnancy
- More time for decisions: If further testing is needed, there’s more time to consider options
- Reduced anxiety: Early screening can alleviate concerns throughout the pregnancy
Unlike some traditional screening tests that must be performed within specific time windows, NIPT can be carried out at any point from 10 weeks onwards, offering flexibility for expectant mothers.
Who Should Consider NIPT?
While NIPT is suitable for most pregnancies, certain factors may make it particularly beneficial:
- Maternal age: Women aged 35 and over have an increased risk of chromosomal abnormalities
- Family history: Previous pregnancies affected by chromosomal conditions
- Abnormal ultrasound findings: Structural abnormalities detected during routine scans
- High-risk screening results: Elevated risk from combined or quadruple screening tests
- IVF pregnancies: Some couples undergoing fertility treatment prefer comprehensive screening
- Personal choice: Any pregnant woman seeking maximum reassurance about chromosomal health
The NHS now offers NIPT to women with higher-chance results from initial screening, but many expectant mothers in London choose private NIPT testing for the convenience and comprehensive options available.
Understanding NIPT Results
NIPT results are reported as either ‘low risk’ or ‘high risk’ for each condition tested. It’s crucial to understand that NIPT is a screening test, not a diagnostic test, meaning it indicates probability rather than providing a definitive diagnosis.
A low-risk result provides significant reassurance, with the chance of the condition being present reduced to less than 1 in 10,000 in most cases. However, a high-risk result doesn’t mean the baby definitely has the condition – it indicates an increased likelihood that requires further investigation through diagnostic testing.
Understanding these statistics can be complex, which is why interpreting NIPT statistics often benefits from professional genetic counselling. The positive predictive value of NIPT varies depending on maternal age, the specific condition, and individual risk factors.
Types of NIPT Available
Several NIPT options are available, ranging from basic screening to comprehensive genetic analysis:
- Basic NIPT: Screens for trisomy 21, 18, and 13, plus sex chromosome abnormalities
- Extended NIPT: Includes additional chromosomal conditions and microdeletion syndromes
- Comprehensive NIPT: Advanced testing covering hundreds of genetic conditions
- Specific tests: Such as PrenatalSafe NIPT or Unity NIPT, each with different coverage levels
The choice between different NIPT types depends on individual preferences, risk factors, and the level of screening coverage desired. More comprehensive tests provide broader screening but come with higher costs and potentially more complex results interpretation.
NIPT vs Traditional Screening
Traditional first-trimester screening combines blood tests measuring pregnancy hormones with ultrasound measurements of nuchal translucency. While this approach has been the standard for years, NIPT offers several advantages:
- Higher accuracy: Detection rates above 99% for Down’s syndrome compared to 85-95% for combined screening
- Lower false positive rates: NIPT has false positive rates below 1% compared to 5% for traditional screening
- No ultrasound dependency: Results don’t rely on scan measurements, which can be operator-dependent
- Single test: Only requires a blood draw rather than coordinating blood tests and scans
However, traditional screening remains valuable as it includes ultrasound assessment of fetal development and can detect structural abnormalities that NIPT cannot identify. Many women opt for both approaches to maximise detection rates.
Limitations of NIPT
While NIPT is highly accurate, it’s important to understand its limitations:
- Screening not diagnostic: Results indicate risk levels, not definitive diagnoses
- Limited scope: Cannot detect neural tube defects, structural abnormalities, or all genetic conditions
- Test failures: Approximately 1-5% of tests may fail due to insufficient fetal DNA
- Placental mosaicism: Rare cases where placental DNA doesn’t match fetal DNA
- Twin pregnancies: Accuracy may be reduced in multiple pregnancies
These limitations highlight why NIPT works best as part of comprehensive prenatal care, often combined with detailed ultrasound scanning and professional genetic counselling when needed.
Considering the Costs
The NHS provides NIPT free of charge for women with higher-chance screening results, but many expectant mothers choose private testing for immediate access and comprehensive options. Private NIPT costs in London vary depending on the test comprehensiveness and clinic chosen.
When considering costs, factor in:
- Test comprehensiveness: More extensive screening panels cost more but provide broader coverage
- Turnaround time: Express services may carry premium pricing
- Genetic counselling: Professional guidance may be included or available as an additional service
- Follow-up care: Consider whether additional support is included if results require further investigation
Many couples view NIPT as an investment in peace of mind during pregnancy, with the reassurance often outweighing the financial consideration.
Making Your Decision
Deciding whether to have NIPT is deeply personal and depends on various factors unique to your situation. Consider these questions when making your choice:
- What level of reassurance do you need? NIPT provides highly accurate screening that can offer significant peace of mind
- How would you use the information? Consider how results might influence your pregnancy journey and decisions
- What are your risk factors? Age, family history, and previous pregnancies may influence the benefits
- Can you handle uncertainty? Remember that screening provides risk assessment, not definitive answers
There’s no right or wrong choice – some women prefer comprehensive screening while others are comfortable with routine NHS care. Modern prenatal screening offers options to suit different preferences and circumstances.
How the London Pregnancy Clinic Can Help
At London Pregnancy Clinic, we offer comprehensive NIPT services with the expertise and support you need to make informed decisions about prenatal screening. Our specialist team provides various screening options, from basic chromosomal screening to advanced genetic analysis covering hundreds of conditions.
Our services include:
- Multiple NIPT options: Choose from various test types to match your screening preferences and requirements
- Expert genetic counselling: Professional guidance to help understand results and implications
- Combined scan packages: NIPT can be combined with detailed ultrasound examinations for comprehensive assessment
- Rapid results: Quick turnaround times to minimise anxiety during the waiting period
- Follow-up support: Continued guidance if results require further investigation or consultation
Our experienced team understands the importance of choosing the right NIPT provider and ensures you receive personalised care throughout your screening journey.
Final Thoughts
NIPT represents a significant advancement in prenatal care, offering expectant mothers highly accurate, safe screening for important chromosomal conditions. While the decision to undergo testing is personal, understanding what NIPT involves and its benefits can help you make the choice that’s right for your family.
Whether you’re seeking basic reassurance about the most common chromosomal conditions or comprehensive screening for hundreds of genetic disorders, NIPT provides valuable information that can enhance your pregnancy journey. The key is choosing the right test and provider to meet your individual needs and circumstances.
If you’re considering NIPT screening, speaking with experienced professionals can help clarify your options and ensure you make an informed decision that provides the reassurance and information you’re seeking during this important time.
Sources
- Non Invasive Prenatal Testing in London – Pregnancy DNA Test
- Non-Invasive Prenatal Testing (NIPT) – The SAFE Test – St George’s University Hospitals NHS Foundation Trust
- SMART Test NIPT Test at the London Pregnancy Clinic
- Non-Invasive Prenatal Testing (NIPT) – Antenatal Results and Choices (ARC)
- What is NIPT? – Genomics Education Programme
- New operational guidance for NIPT screening within the NHS – PHE Screening
- Non-invasive prenatal testing (NIPT) | Imperial College Healthcare Private Care
- Non-invasive prenatal testing (NIPT) — Knowledge Hub
- Presentation: Patient with a higher-chance non-invasive prenatal test (NIPT) result — In the Clinic
- KNOVA NIPT Test London | UK Pioneers in Advanced Screening
- NIPT PPV Calculator – London Pregnancy Clinic
- Non-Invasive Prenatal Testing (NIPT) in London | CRGH
Latest Stories
What is SMA and Why is it Trending Right Now?
What is SMA and Why is it Trending Right Now?
Published
Tags
Spinal muscular atrophy (SMA) has become increasingly prominent in medical discussions, particularly as around 70 children are born with this rare genetic condition each year in the UK. This neuromuscular disorder is trending not only because of breakthrough treatments but also due to enhanced carrier screening tests that can help prospective parents understand their risks. Understanding SMA is crucial for couples planning a family, as early detection and intervention can significantly impact outcomes.
Understanding Spinal Muscular Atrophy
Spinal muscular atrophy is a genetic neuromuscular disorder that causes certain muscles to become weak and waste away. This condition affects the motor neurones in the spinal cord, which are responsible for controlling voluntary muscle movement. When these nerve cells deteriorate, muscles cannot receive the signals they need to function properly, leading to progressive weakness and atrophy.
SMA is caused by mutations in the SMN1 gene, which produces a protein essential for motor neurone survival. Without sufficient levels of this protein, motor neurones gradually die, resulting in muscle weakness that typically affects the muscles closest to the centre of the body first, including those controlling breathing, swallowing, and movement.
The condition follows an autosomal recessive inheritance pattern, meaning both parents must carry a faulty copy of the gene for their child to develop SMA. Our comprehensive spinal muscular atrophy information provides detailed guidance for families considering genetic screening.
The Five Types of SMA
SMA is classified into five distinct types based on the age of onset and severity of symptoms. Understanding these classifications helps healthcare professionals and families plan appropriate care and set realistic expectations.
- SMA Type 0: The most severe form, with symptoms appearing before birth. Babies are born with severe muscle weakness and breathing difficulties.
- SMA Type 1 (Werdnig-Hoffmann disease): Symptoms appear within the first six months of life. Children typically cannot sit without support and face significant breathing and feeding challenges.
- SMA Type 2: Onset occurs between 6-18 months. Children can sit independently but cannot walk unassisted. Most maintain this ability throughout childhood.
- SMA Type 3 (Kugelberg-Welander disease): Symptoms begin after 18 months of age. Children can walk independently initially but may lose this ability over time.
- SMA Type 4: Adult-onset form with mild symptoms that typically don’t affect life expectancy significantly.
The NHS recognises that early diagnosis is crucial, as new treatments are most effective when started as soon as possible after birth.
Why SMA is Trending in Medical Circles
Several factors have brought SMA to the forefront of medical and public attention in recent years. The development of groundbreaking treatments has transformed what was once considered an untreatable condition into one where early intervention can dramatically improve outcomes.
The introduction of gene therapies and other disease-modifying treatments on the NHS has created renewed hope for families affected by SMA. These treatments work best when administered early, making prenatal and newborn screening increasingly important. The success stories emerging from early treatment programmes have captured media attention and raised public awareness.
Additionally, advances in genetic screening technology have made it easier and more accessible for couples to understand their carrier status. Advanced prenatal screening can now detect SMA risk with greater accuracy than ever before, leading to increased uptake of testing services.
High-profile campaigns by patient advocacy groups and increased research funding have also contributed to SMA’s visibility. The condition has gained attention from celebrities and public figures, further raising awareness about this previously little-known genetic disorder.
Carrier Screening and Inheritance Patterns
Approximately one in 40-50 people in the UK carries a faulty copy of the SMN1 gene, making SMA carrier screening particularly relevant for prospective parents. When both parents are carriers, there is a 25% chance with each pregnancy that their child will have SMA, a 50% chance the child will be a carrier, and a 25% chance the child will be unaffected.
Carrier screening can be performed before conception or during early pregnancy. The test involves a simple blood sample that analyses DNA for mutations in the SMN1 gene. Most carriers have no symptoms and are unaware of their status until testing reveals it.
If both partners are identified as carriers, genetic counselling becomes essential. Our genetic counselling services help couples understand their options, which may include prenatal diagnostic testing, preimplantation genetic testing (PGT), or accepting the natural risk.
The Human Fertilisation and Embryology Authority (HFEA) has approved the use of PGT-M for couples at risk of having a child with SMA Types 1, 2, or 3, providing options for family planning before pregnancy occurs.
Symptoms and Early Warning Signs
Recognising the early signs of SMA is crucial for timely intervention. Symptoms vary depending on the type of SMA, but certain warning signs should prompt immediate medical attention.
- Muscle weakness: Progressive weakness that typically affects muscles closest to the torso first, including shoulders, hips, and back.
- Delayed motor milestones: Late achievement of sitting, standing, or walking compared to typical developmental timelines.
- Breathing difficulties: Weak respiratory muscles can cause breathing problems, particularly during sleep or illness.
- Feeding challenges: Difficulty sucking, swallowing, or maintaining adequate nutrition due to weak facial and throat muscles.
- Tremor: Fine trembling of fingers and hands, particularly noticeable when arms are extended.
- Reduced fetal movement: In severe cases, decreased movement may be noticed during pregnancy.
Parents who notice these symptoms should seek immediate medical evaluation. Early diagnosis allows for prompt treatment initiation, which can significantly improve outcomes and quality of life.
Diagnostic Methods and Testing
Diagnosing SMA involves several approaches, depending on when the condition is suspected. Prenatal diagnosis is possible when both parents are known carriers, whilst postnatal diagnosis typically follows clinical suspicion based on symptoms.
Genetic testing remains the gold standard for SMA diagnosis. A blood sample can reveal deletions or mutations in the SMN1 gene that cause the condition. This testing can be performed prenatally through chorionic villus sampling (CVS) or amniocentesis if both parents are carriers.
Additional diagnostic tools may include electromyography (EMG) to assess muscle and nerve function, muscle biopsy in certain cases, and creatine kinase blood tests. However, genetic testing has largely replaced these more invasive procedures.
The UK National Screening Committee continues to evaluate the potential for newborn screening for SMA, recognising that early detection could improve treatment outcomes. Some regions have begun pilot programmes to assess the feasibility and benefits of population-wide newborn screening.
Treatment Breakthroughs and NHS Availability
The treatment landscape for SMA has been revolutionised in recent years, transforming the outlook for affected children and their families. Three main disease-modifying treatments are now available through the NHS, each working through different mechanisms to address the underlying genetic cause.
Spinraza (nusinersen) was the first approved treatment, administered through spinal injections every four months. This antisense oligonucleotide helps increase production of functional SMN protein from the backup SMN2 gene.
Zolgensma represents a breakthrough in gene therapy, providing a functional copy of the SMN1 gene through a single intravenous infusion. This treatment is most effective when given to babies before symptoms develop or in very early stages of the disease.
Evrysdi (risdiplam) offers an oral treatment option, taken daily as a liquid medicine. This small molecule drug increases SMN protein production and can be used across all SMA types and ages.
The NHS has made these treatments available following NICE approval, recognising their potential to dramatically improve outcomes when started early. Success stories include children who have achieved motor milestones previously thought impossible for their SMA type.
Impact on Family Planning Decisions
The availability of effective treatments has significantly influenced how families approach SMA risk in pregnancy planning. Where previously a positive diagnosis might have led to difficult pregnancy decisions, many families now feel more confident proceeding with pregnancies when SMA is detected.
However, the importance of early detection has never been greater. The most effective outcomes occur when treatment begins before symptoms develop, making prenatal diagnosis and immediate postnatal intervention crucial.
Families with a known risk of SMA have several options to consider. Prepregnancy genetic testing can identify carrier status before conception, allowing couples to make informed decisions about their reproductive choices.
For families who choose to proceed with a pregnancy at risk for SMA, comprehensive prenatal care and planning for immediate postnatal intervention becomes essential. This includes coordination with specialist neuromuscular centres and preparation for early treatment initiation if needed.
The Role of Genetic Counselling
Genetic counselling plays a vital role in helping families navigate SMA-related decisions. Professional genetic counsellors provide essential support in understanding inheritance patterns, risk assessment, and available options for testing and family planning.
During counselling sessions, families learn about the implications of carrier status, the likelihood of having an affected child, and the various testing options available. Counsellors also provide emotional support and help families process complex medical information.
For families with an SMA diagnosis, genetic counselling extends to discussing treatment options, coordinating care with specialist centres, and planning for future pregnancies. The recurrence risk remains 25% for subsequent pregnancies, making ongoing genetic counselling valuable.
Our genetic testing and counselling services provide comprehensive support throughout this process, ensuring families have access to accurate information and emotional support when making these important decisions.
Latest Research and Future Developments
Research into SMA continues to advance rapidly, with several promising developments on the horizon. Scientists are investigating combination therapies that might provide even greater benefits than current single treatments.
Studies are exploring the potential for prenatal treatment, where therapy could begin before birth to prevent symptom development entirely. Early research suggests this approach might offer the best possible outcomes for the most severe forms of SMA.
Improved screening methods are also under development, including more comprehensive carrier screening panels and enhanced newborn screening protocols. These advances could identify more at-risk pregnancies and affected newborns, enabling earlier intervention.
Long-term outcome studies are providing valuable data about the effectiveness of current treatments, helping clinicians optimise treatment protocols and timing. This research is particularly important for understanding how early intervention affects long-term development and quality of life.
How the London Pregnancy Clinic Can Help
The London Pregnancy Clinic offers comprehensive genetic screening and counselling services to support families concerned about SMA and other genetic conditions. Our experienced team provides expert guidance throughout the screening and diagnostic process.
We offer advanced carrier screening tests that can identify SMA carrier status in prospective parents. Our clinical genetics consultations provide detailed risk assessment and counselling for couples considering their family planning options.
For pregnancies identified as being at risk for SMA, we provide specialised prenatal diagnostic services and coordinate care with leading fetal medicine specialists. Our genetic counselling sessions ensure families receive comprehensive support and information to make informed decisions.
We also offer advanced prenatal screening through NIPT and other genetic testing options, helping identify pregnancies that may benefit from further diagnostic testing. Our state-of-the-art facilities and expert sonographers provide detailed ultrasound assessments when indicated.
Final Thoughts
Spinal muscular atrophy represents both a significant challenge and a remarkable success story in modern genetics and medicine. The transformation from an untreatable condition to one where early intervention can dramatically improve outcomes demonstrates the power of scientific advancement and dedicated research.
For prospective parents, understanding SMA and carrier screening options has never been more important. The availability of effective treatments means that early detection and intervention can make a profound difference in a child’s development and quality of life.
If you’re concerned about genetic conditions like SMA or considering carrier screening, our expert team is here to provide guidance and support. Contact the London Pregnancy Clinic to discuss your options and ensure you have access to the latest screening technologies and genetic counselling services.
Sources
- SMA (Spinal Muscular Atrophy): What It Is, Symptoms & Types
- Carrier Screening for Spinal Muscular Atrophy (SMA) | ACOG
- Presentation: Pregnancy at risk of spinal muscular atrophy — In the Clinic
- Family Planning For Couples Affected By 5q SMA – SMAUK
- Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy – PMC
- Spinal muscular atrophy (SMA) – NHS
- Spinal muscular atrophy – UK National Screening Committee (UK NSC) – GOV.UK
- NHS England » New NHS treatments helping extend survival for babies with rare muscle-wasting disease
- Spinal muscular atrophy (SMA) | Great Ormond Street Hospital
- Spinal muscular atrophy type 1: NCARDRS report – NDRS
- Spinal muscular atrophy (SMA) – Muscular Dystrophy UK
- Spinal Muscular Atrophy (SMA) | Nemours KidsHealth
Latest Stories
KNOVA NIPT: London Pregnancy Clinic Pioneers Advanced Genetic Screening in the UK
KNOVA NIPT: London Pregnancy Clinic Pioneers Advanced Genetic Screening in the UK
Published
Tags
The London Pregnancy Clinic stands as the pioneering force behind introducing KNOVA NIPT to the United Kingdom, establishing ourselves as the country’s leading authority in this revolutionary genetic screening technology. With hundreds of successful KNOVA NIPT procedures completed, our clinical team possesses unparalleled expertise that no other UK clinic can match, offering expectant parents the most advanced non-invasive prenatal testing available today.
What is KNOVA NIPT?
KNOVA NIPT (Non-Invasive Prenatal Testing) represents the cutting-edge of genetic screening technology, developed by Fulgent Genetics to provide comprehensive chromosomal analysis from a simple maternal blood sample. Unlike traditional screening methods, KNOVA NIPT can detect a wide range of genetic conditions with exceptional accuracy, typically achieving over 99% detection rates for common trisomies including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
This revolutionary test analyses cell-free foetal DNA circulating in the mother’s bloodstream, eliminating the need for invasive procedures such as amniocentesis or chorionic villus sampling. The technology behind KNOVA NIPT utilises advanced sequencing techniques to examine chromosomal abnormalities, microdeletions, and other genetic variations that could impact your baby’s health and development.
What sets KNOVA NIPT apart from other screening options is its comprehensive scope, capable of detecting up to 100 different chromosomal and genetic conditions. This extensive coverage provides expectant parents with detailed insights into their baby’s genetic profile, enabling informed decision-making throughout their pregnancy journey.
London Pregnancy Clinic: The UK’s KNOVA NIPT Pioneers
The London Pregnancy Clinic holds the distinguished position of being the first healthcare provider to introduce KNOVA NIPT to the United Kingdom. Our pioneering status isn’t merely historical; it represents years of dedicated research, clinical validation, and continuous refinement of testing protocols to ensure optimal outcomes for our patients.
Having performed hundreds of KNOVA NIPT procedures, our clinical team has accumulated invaluable expertise that extends far beyond simple test administration. We understand the nuances of patient counselling, the intricacies of result interpretation, and the importance of providing comprehensive support throughout the testing process. This depth of experience enables us to guide expectant parents through every aspect of their genetic screening journey with confidence and compassion.
Our pioneering work with KNOVA NIPT has established protocols and best practices that other clinics across the UK now follow. We continue to collaborate with Fulgent Genetics to advance the technology further, ensuring our patients always receive the most current and comprehensive genetic screening available. This commitment to innovation and excellence has made us the preferred choice for healthcare professionals and expectant parents seeking the highest standard of prenatal genetic testing.
The Science Behind KNOVA NIPT Excellence
KNOVA NIPT employs sophisticated next-generation sequencing (NGS) technology to analyse cell-free foetal DNA with remarkable precision. During pregnancy, small fragments of the baby’s DNA circulate in the mother’s bloodstream, typically comprising 3-13% of the total circulating DNA. Our laboratory partners utilise advanced bioinformatics algorithms to distinguish between maternal and foetal DNA sequences, enabling accurate detection of chromosomal abnormalities.
The test’s exceptional accuracy stems from its ability to analyse millions of DNA fragments simultaneously, creating a comprehensive genetic profile that traditional screening methods cannot achieve. This technological advancement allows KNOVA NIPT to detect not only common trisomies but also rare chromosomal conditions and microdeletions that affect fewer than 1 in 1000 pregnancies.
Our expertise in KNOVA NIPT extends to understanding the technical limitations and optimal timing for testing. We recommend performing the test after 9 weeks of pregnancy when foetal DNA levels are sufficient for accurate analysis. Our experienced phlebotomists ensure proper sample collection and handling, whilst our clinical team provides thorough pre-test counselling to ensure patients understand the scope and limitations of the screening.
Comprehensive Genetic Conditions Detected
KNOVA NIPT’s comprehensive screening capability encompasses a broad spectrum of genetic conditions, making it the most thorough non-invasive prenatal test available in the UK. The test categorises conditions into several key areas, each providing crucial information about your baby’s genetic health.
- Common Trisomies: Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13) with over 99% detection accuracy.
- Sex Chromosome Abnormalities: Turner syndrome, Klinefelter syndrome, Triple X syndrome, and XYY syndrome affecting sexual development and fertility.
- Rare Trisomies: Additional chromosomal duplications including Trisomies 9, 16, and 22 that can impact foetal development.
- Microdeletions: Small chromosomal deletions including 22q11.2 deletion syndrome (DiGeorge syndrome), Prader-Willi syndrome, and Angelman syndrome.
- Copy Number Variants: Chromosomal duplications and deletions that may affect intellectual development and physical characteristics.
Our extensive experience with KNOVA NIPT enables us to provide detailed counselling about each condition, helping parents understand the implications of positive results and the importance of confirmatory testing when necessary.
The KNOVA NIPT Testing Process
Our streamlined KNOVA NIPT process reflects years of refinement based on hundreds of successful procedures. The journey begins with a comprehensive consultation where our specialist team discusses your medical history, family background, and specific concerns about genetic conditions. This personalised approach ensures that KNOVA NIPT is appropriate for your individual circumstances.
The testing procedure itself is remarkably straightforward, requiring only a simple blood draw from the expectant mother. Our experienced phlebotomists ensure comfortable sample collection using specialised tubes designed to preserve cell-free DNA integrity. We combine this blood test with a detailed pregnancy assessment including ultrasound scanning to confirm gestational age and foetal viability.
Sample processing occurs in Fulgent Genetics’ state-of-the-art laboratories, where advanced sequencing technology analyses the genetic material. Results are typically available within 7-10 working days, after which our clinical team schedules a comprehensive results consultation to discuss findings, answer questions, and provide ongoing support as needed.
Clinical Advantages of Our Expertise
Our position as the UK’s KNOVA NIPT pioneers translates into tangible clinical advantages for our patients. Having performed hundreds of these tests, we have developed sophisticated protocols for managing complex cases, including multiple pregnancies, previous pregnancy complications, and patients with specific risk factors that may affect test accuracy.
Our clinical team’s extensive experience enables us to identify cases where KNOVA NIPT may provide inconclusive results, such as maternal mosaicism or confined placental mosaicism. We have established clear pathways for managing these situations, including repeat testing protocols and alternative screening strategies when appropriate.
Furthermore, our expertise extends to post-test management, including coordination with specialist genetic counsellors, foetal medicine specialists, and other healthcare providers when positive results require further investigation. We maintain strong relationships with leading UK genetic centres, ensuring seamless referral pathways for confirmatory testing and ongoing care.
Integration with the SMART Test Programme
KNOVA NIPT forms the cornerstone of our innovative SMART Test programme, which combines advanced genetic screening with detailed ultrasound assessment. This comprehensive approach, developed exclusively at the London Pregnancy Clinic, provides the most thorough evaluation of foetal health available in the UK.
The SMART Test KNOVA package includes two expert foetal scans alongside the genetic screening, creating a dual approach that maximises detection of both genetic and structural abnormalities. Our specialist sonographers perform detailed anatomical surveys whilst the KNOVA NIPT analyses chromosomal integrity, providing complementary information that enhances overall screening accuracy.
This integrated approach reflects our understanding that genetic conditions often have physical manifestations that can be detected through expert ultrasound examination. By combining these modalities, we can provide expectant parents with the most comprehensive assessment of their baby’s health, backed by our unparalleled expertise in both genetic screening and prenatal imaging.
Accuracy and Reliability
KNOVA NIPT demonstrates exceptional accuracy rates that have been validated through our extensive clinical experience. For common trisomies, the test achieves sensitivity rates exceeding 99%, with false positive rates remaining below 0.1%. These performance metrics represent real-world outcomes from our hundreds of completed tests, providing robust evidence of the technology’s clinical reliability.
Our experience has enabled us to identify factors that may influence test reliability such as medical history and genetic conditions. We use this knowledge to optimise testing protocols and provide patients with realistic expectations about test performance in their specific circumstances.
It’s important to understand that KNOVA NIPT is a screening test, not a diagnostic procedure. Positive results require confirmatory testing through amniocentesis or chorionic villus sampling. Our extensive experience includes managing the emotional and clinical aspects of positive results, ensuring patients receive appropriate support and timely access to confirmatory procedures when needed.
Patient Experience and Support
Our pioneering experience with KNOVA NIPT has taught us that technical excellence must be matched with exceptional patient care. We understand that genetic screening can provoke anxiety and uncertainty, which is why we have developed comprehensive support protocols that address both the clinical and emotional aspects of prenatal testing.
From initial consultation through results delivery, our patients benefit from continuous access to specialist support. We provide detailed pre-test counselling that explains the scope of conditions tested, the meaning of results, and the implications for pregnancy management. This educational approach empowers patients to make informed decisions about their genetic screening options.
Our post-test support includes detailed results consultations, access to genetic counselling services, and coordination with other specialists when additional care is required. We maintain long-term relationships with our patients, providing ongoing support throughout pregnancy and beyond when genetic conditions are identified.
Comparing KNOVA NIPT to Other Tests
Our extensive experience with multiple NIPT platforms positions us uniquely to advise patients about the advantages of KNOVA NIPT compared to alternative screening options. Unlike more limited tests that screen for only common trisomies, KNOVA NIPT provides comprehensive analysis of up to 100 genetic conditions, offering unparalleled screening breadth.
Traditional NHS screening programmes, whilst valuable, cannot match the scope and accuracy of KNOVA NIPT. The combined first trimester screening offered through the NHS detects approximately 85% of Down syndrome cases, compared to KNOVA NIPT’s >99% detection rate. Additionally, NHS screening cannot detect the rare genetic conditions and microdeletions that KNOVA NIPT identifies.
When compared to other private NIPT options, KNOVA NIPT’s comprehensive panel and advanced technology provide superior clinical value. Our experience demonstrates that patients increasingly prefer comprehensive screening that can detect rare conditions, particularly when family history or other risk factors suggest increased genetic risk.
How the London Pregnancy Clinic Can Help
As the UK’s pioneering KNOVA NIPT provider, the London Pregnancy Clinic offers unmatched expertise in advanced prenatal genetic screening. Our specialist team combines extensive clinical experience with state-of-the-art technology to provide the most comprehensive genetic assessment available to expectant parents.
We offer flexible appointment scheduling at our modern clinic locations, with same-day results consultations available when needed. Our integrated approach combines KNOVA NIPT with expert ultrasound assessment, providing comprehensive evaluation of both genetic and structural foetal development.
Our commitment to excellence extends beyond testing to include comprehensive patient support, detailed counselling services, and seamless coordination with other specialists when additional care is required. We maintain the highest standards of clinical governance whilst providing the personalised care that makes genetic screening as comfortable and informative as possible.
For expectant parents seeking the most advanced genetic screening available, combined with unparalleled clinical expertise, the London Pregnancy Clinic represents the gold standard in UK prenatal care. Our pioneering work with KNOVA NIPT continues to set new benchmarks for genetic screening excellence.
Final Thoughts
The London Pregnancy Clinic’s pioneering role in introducing KNOVA NIPT to the UK reflects our unwavering commitment to advancing prenatal care through innovative technology and clinical excellence. Our extensive experience with hundreds of successful procedures has established us as the nation’s leading authority in comprehensive genetic screening.
For expectant parents seeking the most advanced genetic screening available, KNOVA NIPT offers unparalleled insight into their baby’s genetic health. Combined with our expert clinical team’s guidance and support, this technology provides the foundation for informed decision-making throughout pregnancy.
If you’re considering genetic screening during pregnancy, we invite you to benefit from our pioneering expertise and comprehensive approach to prenatal care. Contact the London Pregnancy Clinic today to schedule your consultation and discover how our KNOVA NIPT experience can provide you with the confidence and reassurance you deserve during this important time.
Latest Stories
Gestational Diabetes: A Complete Guide for Expecting Mothers
Gestational Diabetes: A Complete Guide for Expecting Mothers
Published
Tags
Gestational diabetes affects approximately 1 in 20 pregnancies in the UK, making it one of the most common pregnancy complications. This form of glucose intolerance develops during pregnancy in women who didn’t previously have diabetes, and whilst it can feel overwhelming to receive this diagnosis, understanding the condition and following proper management can lead to excellent outcomes for both mother and baby.
What is Gestational Diabetes?
Gestational diabetes mellitus (GDM) is a condition characterised by elevated blood glucose levels that develops during pregnancy. Unlike type 1 or type 2 diabetes, gestational diabetes typically appears between 24-28 weeks of pregnancy and usually resolves after delivery, though it does increase the risk of developing type 2 diabetes later in life.
The condition occurs when pregnancy hormones interfere with insulin’s ability to regulate blood sugar effectively. During pregnancy, the placenta produces hormones that help the baby develop, but these same hormones can block the action of insulin in the mother’s body, a condition called insulin resistance.
When the body cannot produce enough insulin to overcome this resistance, blood glucose levels rise, leading to gestational diabetes. This typically develops in the second or third trimester when hormone levels are at their highest.
Understanding the Causes and Risk Factors
Whilst any pregnant woman can develop gestational diabetes, certain factors increase the likelihood of developing this condition. The NHS and NICE guidelines identify several key risk factors that healthcare providers consider when assessing pregnancy care.
The primary risk factors include:
- Body mass index (BMI) of 30kg/m² or above: Excess weight can contribute to insulin resistance
- Previous gestational diabetes: Having had the condition in a previous pregnancy significantly increases risk
- Family history: A parent or sibling with diabetes increases susceptibility
- Ethnicity: Women of South Asian, Black Caribbean, or Middle Eastern origin have higher risk
- Previous large baby: Having previously given birth to a baby weighing 4.5kg (10lbs) or more
- Age: Women over 40 have increased risk
- Polycystic ovary syndrome (PCOS): This hormonal condition is associated with insulin resistance
It’s important to understand that having risk factors doesn’t guarantee you’ll develop gestational diabetes, and some women develop the condition without any identifiable risk factors.
Recognising the Symptoms
One of the challenges with gestational diabetes is that it often presents with mild or no obvious symptoms, which is why routine screening is so important. Many symptoms can be mistaken for normal pregnancy changes, making professional monitoring essential.
When symptoms do occur, they may include:
- Excessive thirst: Feeling unusually thirsty despite drinking plenty of fluids
- Frequent urination: Needing to urinate more often than typical for your stage of pregnancy
- Fatigue: Feeling more tired than expected, even accounting for normal pregnancy tiredness
- Blurred vision: Changes in vision due to fluctuating blood sugar levels
- Recurring infections: Particularly thrush or urinary tract infections
- Nausea: Feeling sick, especially if this develops later in pregnancy
Because these symptoms can overlap with normal pregnancy experiences, many women with gestational diabetes are diagnosed through routine screening rather than symptom presentation. This emphasises the importance of attending all scheduled antenatal appointments.
Diagnosis and Screening Process
The diagnosis of gestational diabetes typically occurs through an oral glucose tolerance test (OGTT), usually performed between 24-28 weeks of pregnancy. However, women with higher risk factors may be offered earlier testing.
The OGTT involves several steps:
- Fasting blood test: You’ll need to fast overnight, then have blood taken to measure fasting glucose levels
- Glucose drink: You’ll be given a glucose solution to drink
- Follow-up tests: Blood samples are taken at one and two hours after drinking the solution
- Results interpretation: Your healthcare team will analyse the results against established thresholds
According to NICE guidelines, gestational diabetes is diagnosed when fasting plasma glucose is 5.6 mmol/L or above, or when the 2-hour plasma glucose is 7.8 mmol/L or above. Some women may also have random glucose testing or glucose monitoring through early pregnancy scans if risk factors are particularly high.
Treatment and Management Approaches
Managing gestational diabetes focuses on controlling blood glucose levels to protect both mother and baby. The good news is that with proper management, most women with gestational diabetes have healthy pregnancies and babies.
Treatment typically follows a stepped approach:
First-line management includes:
- Dietary modifications: Working with a dietitian to develop a balanced eating plan
- Regular exercise: Safe, appropriate physical activity to help regulate blood sugar
- Blood glucose monitoring: Regular home testing to track glucose levels
- Weight management: Maintaining healthy weight gain during pregnancy
Medical intervention may include:
- Metformin: An oral medication that helps improve insulin sensitivity
- Insulin therapy: Prescribed when fasting glucose remains elevated despite lifestyle changes
- Combination therapy: Using both metformin and insulin when required
The NHS recommends immediate medical treatment for women with fasting plasma glucose levels of 7.0 mmol/L or above, as this indicates a higher risk of complications.
Dietary Management and Lifestyle Changes
Diet plays a crucial role in managing gestational diabetes, and many women find they can control their blood glucose levels effectively through nutritional changes alone. The key is understanding how different foods affect blood sugar and timing meals appropriately.
Effective dietary strategies include:
- Carbohydrate awareness: Learning to identify and portion complex carbohydrates appropriately
- Regular meal timing: Eating smaller, frequent meals to avoid glucose spikes
- Fibre-rich foods: Including plenty of vegetables, whole grains, and legumes
- Protein balance: Ensuring adequate protein intake to help stabilise blood sugar
- Healthy fats: Including sources like avocados, nuts, and olive oil
- Avoiding processed foods: Limiting refined sugars and highly processed items
Exercise is equally important, with activities like brisk walking, swimming, or pregnancy yoga helping to improve insulin sensitivity. The NHS recommends at least 150 minutes of moderate-intensity exercise per week during pregnancy, unless contraindicated.
Working with healthcare professionals, including specialist midwives and dietitians, ensures that dietary and lifestyle modifications are safe and appropriate for your individual circumstances.
Monitoring Your Baby’s Growth and Wellbeing
Gestational diabetes can affect foetal growth and development, making regular monitoring essential throughout pregnancy. Elevated maternal blood glucose levels can lead to increased foetal growth, particularly in the baby’s shoulders and torso, a condition known as macrosomia.
Enhanced monitoring typically includes:
- Serial growth scans: Regular ultrasound examinations to monitor baby’s size and growth patterns
- Amniotic fluid assessment: Checking for polyhydramnios (excess amniotic fluid)
- Foetal wellbeing tests: Including movements monitoring and potentially CTG (cardiotocography)
- Placental assessment: Monitoring placental function and blood flow
These growth scans help healthcare providers track whether gestational diabetes is affecting the baby’s development and inform decisions about timing of delivery and birth planning. Regular monitoring allows for early intervention if any concerns arise.
Most babies born to mothers with well-controlled gestational diabetes are healthy, but monitoring ensures any potential issues are identified and managed promptly.
Potential Complications and Risks
Whilst gestational diabetes can be effectively managed, it’s important to understand potential complications to emphasise the importance of proper treatment and monitoring. Most complications can be prevented or minimised with good glucose control.
Maternal complications may include:
- Pre-eclampsia: Gestational diabetes increases the risk of developing this serious pregnancy condition
- Increased birth complications: Higher likelihood of instrumental delivery or caesarean section
- Future diabetes risk: Increased chance of developing type 2 diabetes later in life
- Polyhydramnios: Excess amniotic fluid leading to premature labour risk
Foetal and neonatal complications may include:
- Macrosomia: Babies growing larger than average, potentially complicating delivery
- Neonatal hypoglycaemia: Low blood sugar in the baby after birth
- Respiratory distress: Breathing difficulties immediately after birth
- Increased diabetes risk: Higher likelihood of developing diabetes in childhood or adulthood
It’s crucial to remember that with proper management and monitoring, the vast majority of women with gestational diabetes have uncomplicated pregnancies and healthy babies. These potential complications emphasise why following treatment recommendations is so important.
Birth Planning and Delivery Considerations
Having gestational diabetes may influence your birth plan and delivery timing, though many women with well-controlled gestational diabetes can have normal, vaginal deliveries. Your obstetric team will work with you to develop an appropriate birth plan based on your individual circumstances.
Key considerations include:
- Timing of delivery: Most women deliver around their due date, though early delivery may be recommended in some cases
- Induction considerations: Labour may be induced if there are concerns about baby’s size or maternal glucose control
- Blood glucose monitoring: Glucose levels will be monitored throughout labour
- Insulin management: Adjustments to insulin therapy during labour if applicable
- Neonatal care planning: Ensuring appropriate monitoring for the baby after birth
During labour and delivery, your healthcare team will monitor both your blood glucose levels and your baby’s wellbeing. If you’ve been taking insulin, your dosage may need adjustment during labour as your body’s needs change.
Most hospitals have established protocols for managing women with gestational diabetes during delivery, ensuring both mother and baby receive appropriate care throughout the birthing process.
Postpartum Care and Long-term Health
For most women, blood glucose levels return to normal shortly after delivery as pregnancy hormones decrease. However, having gestational diabetes does have implications for long-term health that require ongoing attention.
Immediate postpartum care includes:
- Blood glucose monitoring: Checking levels return to normal after delivery
- Medication cessation: Stopping gestational diabetes medications if no longer needed
- Baby’s glucose monitoring: Ensuring newborn’s blood sugar levels are stable
- Breastfeeding support: Which can help regulate both mother’s and baby’s glucose levels
Long-term considerations include:
- Diabetes screening: Having glucose tolerance tests 6-13 weeks postpartum and annually thereafter
- Lifestyle maintenance: Continuing healthy eating and exercise habits
- Future pregnancy planning: Understanding increased risk in subsequent pregnancies
- Family health awareness: Monitoring children for signs of diabetes as they grow
Research shows that up to 50% of women who have gestational diabetes will develop type 2 diabetes within 10 years, making long-term monitoring and preventive measures crucial for maintaining health.
How the London Pregnancy Clinic Can Help
At the London Pregnancy Clinic, we understand that a gestational diabetes diagnosis can feel overwhelming. Our experienced team provides comprehensive support and monitoring throughout your pregnancy journey, ensuring you receive the highest standard of care in a comfortable, private setting.
Our gestational diabetes management services include:
- Specialist consultations: Access to consultant obstetricians with expertise in high-risk pregnancies
- Advanced monitoring: State-of-the-art ultrasound equipment for detailed growth and wellbeing assessments
- Flexible appointment scheduling: Regular monitoring appointments that fit around your schedule
- Comprehensive care coordination: Seamless communication with your NHS team and other healthcare providers
- Educational support: Detailed guidance on managing your condition and understanding your care plan
Our specialist sonographers use the latest ultrasound technology to monitor your baby’s growth and development, providing detailed assessments that complement your NHS care. We offer pregnancy scan packages designed specifically for women requiring enhanced monitoring.
Located in central London with convenient appointment times, we make it easier for you to access the additional monitoring and support you need during your pregnancy with gestational diabetes.
Final Thoughts
Receiving a gestational diabetes diagnosis can initially feel daunting, but it’s important to remember that this condition is manageable and most women go on to have healthy pregnancies and babies. With proper monitoring, lifestyle adjustments, and medical support when needed, you can maintain excellent health throughout your pregnancy.
The key to successful management lies in working closely with your healthcare team, following dietary and lifestyle recommendations, and attending all scheduled monitoring appointments. Regular blood glucose testing and foetal monitoring ensure that both you and your baby remain healthy throughout pregnancy.
If you’re managing gestational diabetes or have concerns about your pregnancy, the London Pregnancy Clinic is here to provide expert care and support. Our team of specialists can work alongside your NHS care to ensure you receive comprehensive monitoring and guidance throughout your pregnancy journey. Contact us today to learn how our services can support your healthy pregnancy.
Sources
- Diabetes in pregnancy (gestational diabetes) – How gestational diabetes can affect your pregnancy | Guy’s and St Thomas’ NHS Foundation Trust
- Gestational Diabetes – StatPearls – NCBI Bookshelf
- Diabetes in pregnancy (gestational diabetes) – Overview | Guy’s and St Thomas’ NHS Foundation Trust
- Gestational Diabetes: Causes, Symptoms & Treatment
- Gestational Diabetes Mellitus (GDM) | Johns Hopkins Medicine
- Gestational diabetes – UK National Screening Committee (UK NSC) – GOV.UK
- Diabetes, Guidelines for the Management of Diabetes Mellitus during Pregnancy and Diagnosis of Gestational Diabetes (1136) | Right Decisions
- Gestational diabetes – Treatment – NHS
- The Diabetes Specialist Midwife will offer women with a …
- 1 Diabetes in Pregnancy Guideline NW MMN Version 0.2 Date: 17.03.2025
- Gestational diabetes – NHS
- Gestational diabetes mellitus – Symptoms, diagnosis and treatment | BMJ Best Practice US
Latest Stories
London Pregnancy Clinic West
Your Trusted Experts in West London
London Pregnancy Clinic Expands to Chelsea
-
Published
-
Last Modified
Tags
London Pregnancy Clinic is thrilled to announce the opening of its second location in Chelsea, West London, hosted within the prestigious Westminster Women’s Clinic. This expansion brings trusted services, including early pregnancy scans, viability scans, and advanced NIPT options such as PrenatalSafe and SMART Test, closer to West London families. Supported by a highly skilled team and advanced technology, the clinic offers personalised care in a serene environment. Book your appointment today for world-class pregnancy support.
We are delighted to announce the opening of London Pregnancy Clinic’s second location in Chelsea, West London. This expansion reflects our mission to make expert prenatal care and early pregnancy diagnostics accessible to even more expectant mothers across London.
A Partnership with Westminster Women’s Clinic
This exciting new chapter for London Pregnancy Clinic is hosted within the renowned Westminster Women’s Clinic (WWC) in Chelsea. Known for its outstanding reputation in women’s healthcare, WWC provides a state-of-the-art environment that aligns perfectly with our commitment to delivering excellence in care.
Miss Jess McMicking, founder of WWC, shared her enthusiasm about this collaboration, saying, “Very much looking forward to having London Pregnancy Clinic and their exceptional team in our surrounds, and most importantly, their expertise for our patients and the wider West London community.”
This partnership allows London Pregnancy Clinic to offer its trusted services in a setting renowned for prioritising women’s health, ensuring every patient feels supported and cared for during their journey.
Comprehensive Services Tailored to Your Pregnancy
At the Chelsea clinic, you will find the same exceptional care that has earned London Pregnancy Clinic a trusted name in pregnancy health. Early pregnancy scans are available to provide reassurance during the critical first trimester, while viability and dating scans help confirm pregnancy progression and determine your baby’s due date. Advanced Non-Invasive Prenatal Testing (NIPT), including the PrenatalSafe NIPT and SMART Test, ensures accurate screening for chromosomal conditions like Down syndrome.
With over 30 years of expertise in Obstetrics and Gynaecology, our team ensures every service is delivered using cutting-edge ultrasound technology, providing accurate results in a calm and supportive environment.
Why Choose London Pregnancy Clinic in Chelsea?
The new clinic in Chelsea makes expert prenatal care accessible to mothers in West London, including Chelsea, Fulham, Kensington, Knightsbridge, and nearby areas. Situated within Westminster Women’s Clinic, the location combines the welcoming atmosphere and advanced diagnostic tools that are central to the London Pregnancy Clinic experience. From the moment you arrive, you will feel supported in a serene environment where your well-being is the priority.
Meet New Our Expert Team
We are proud to introduce new members of the London Pregnancy Clinic team who will be based at both the City and Chelsea locations. Saskia Hicks, a knowledgeable midwife, brings a compassionate approach to guiding expectant mothers. Eden Ovadia, our dedicated medical assistant, ensures patients feel comfortable and well-cared-for during every visit. Victoria Bennet, an experienced sonographer, offers advanced fetal imaging expertise, while Lih-Wen Wang, a skilled medical assistant and phlebotomist, brings professionalism and care to every interaction.
Looking Ahead: Expanding Services in Chelsea
While our Chelsea location already offers exceptional prenatal care, including early pregnancy scans, viability scans, and advanced NIPT options such as PrenatalSafe and SMART Test, we are committed to bringing even more comprehensive services to West London in the near future.
Plans are underway to introduce midwifery services, allowing us to provide expectant mothers with continuous, personalised support throughout their pregnancy journey. From antenatal appointments to postpartum care, our future midwifery services aim to offer holistic care for mothers and babies alike.
We are also looking to expand our offerings to include fertility screenings and consultations, ensuring that women seeking support with conception have access to expert guidance and diagnostics close to home. Whether it’s follicle tracking scans or pre-conception assessments, these services will help us provide well-rounded care to individuals and families at every stage of their reproductive journey.
Our goal is to ensure that our Chelsea clinic becomes a one-stop destination for women’s health in West London, with an emphasis on expert care, state-of-the-art facilities, and a compassionate approach. As we continue to grow, we remain dedicated to listening to our patients and evolving to meet their needs.
Final Thoughts
Whether you’re seeking early pregnancy scans, prenatal testing, or reassurance during your pregnancy journey, our Chelsea clinic is here to provide expert, compassionate care. Book your appointment today to receive world-class care tailored to your needs. Visit our booking system to learn more and schedule your visit.
Latest Stories
Basic vs Extended NIPT
Choosing the Best NIPT Clinic in London: A Comprehensive Guide for Expectant Parents
Published
Tags
Non-invasive prenatal testing (NIPT) has revolutionised prenatal screening by providing expectant parents with a highly accurate and safe method of detecting genetic conditions in the fetus. However, not all NIPTs are created equal. Understanding the difference between basic and extended NIPT is crucial for making informed decisions during pregnancy. In this article, we will explore the key distinctions between these two types of NIPT and the implications they have for prenatal care.
What is Basic NIPT?
Basic NIPT focuses primarily on detecting common chromosomal aneuploidies. These include:
- Trisomy 21 (Down syndrome): The most frequently occurring aneuploidy, characterised by an extra copy of chromosome 21. This condition is associated with a spectrum of developmental delays, intellectual disabilities, and physical features such as hypotonia, a flat facial profile, and a single palmar crease.
- Trisomy 18 (Edwards syndrome): Associated with severe developmental delays and physical abnormalities.
- Trisomy 13 (Patau syndrome): A rare but severe condition linked to profound developmental issues.
- Many basic NIPTs include sex chromosome aneuploidies, conditions that affect the number of X or Y chromosomes, such as Turner syndrome (45,X) and Klinefelter syndrome (47,XXY).
Basic NIPT typically provides results with high sensitivity and specificity for these conditions. Among the conditions tested, NIPT has the highest sensitivity and specificity for trisomy 21, and its diagnostic performance is lower for trisomy 18 and trisomy 13. However, sex chromosome aneuploidies are known to have a relatively low positive predictive value (PPV), which means they may result in a high false positive rate.
What is Extended NIPT?
Extended NIPT goes beyond the common aneuploidies to screen for additional genetic conditions. This comprehensive approach includes three distinct levels of genetic screening:
Aneuploidies
As with basic NIPT, extended screening includes common trisomies (Down, Edwards, and Patau syndromes) and sex chromosome aneuploidies, but it also assesses rarer autosomal aneuploidies affecting other chromosomes. Importantly, checking for additional syndromes does not compromise the performance of the test for trisomy 21 (Down syndrome).
Microdeletions
Microdeletions are variants of structural chromosomal anomalies. They involve the loss of small but critical segments of DNA within a chromosome. These missing segments can contain multiple important genes, leading to severe and sometimes life-altering conditions. Some microdeletions are more severe than Down syndrome (trisomy 21). Examples of microdeletion syndromes are:
- 22q11.2 deletion syndrome (DiGeorge syndrome): Associated with heart defects, immune dysfunction, and developmental delays.
- Cri-du-chat syndrome: Caused by a deletion on chromosome 5, leading to intellectual disability and distinctive physical features.
- Prader-Willi and Angelman syndromes: Resulting from deletions on chromosome 15, with unique clinical presentations.
Single-Gene Disorders (monogenic syndromes)
Most genetic syndromes in children are related to monogenic (single-gene) disorders. These tests screen for mutations in individual genes that may cause de novo or hereditary conditions. Many of these single-gene disorders can be associated with physical and/or intellectual disabilities. Examples include:
- Achondroplasia: A de novo mutation resulting in a common form of dwarfism.
- Apert syndrome: A genetic condition characterised by craniosynostosis (premature fusion of skull bones), distinctive facial features, and fusion of fingers, often leading to functional and aesthetic challenges.
- Noonan syndrome: A condition with features like heart defects, developmental delays, and distinct facial characteristics.
- Cystic fibrosis: A hereditary condition affecting the respiratory and digestive systems.
Benefits of Extended NIPT
Extended NIPT provides a more detailed assessment of the fetus’s genetic health. It is particularly advantageous in the following scenarios:
- High-risk pregnancies: For parents with a family history of genetic conditions, prior pregnancies affected by genetic disorders, advanced maternal and/or paternal age, or IVF pregnancies, extended screening can offer invaluable insights.
- Unexplained ultrasound findings: When ultrasound findings or abnormalities suggest a potential genetic condition, extended NIPT can help clarify the diagnosis.
- In cases of increased nuchal translucency (high NT), when parents prefer to avoid invasive diagnostic tests such as CVS or amniocentesis and opt for NIPT, it is essential to consider the limitations of basic NIPT. Basic NIPT does not screen for many genetic syndromes associated with increased NT. In such situations, extended NIPT can be a preferred option, as it includes screening for monogenic conditions like Noonan syndrome, Kabuki syndrome, severe skeletal dysplasias, and other syndromes, as well as microdeletions such as 22q11.2 deletion syndrome (DiGeorge syndrome).
- An additional test after normal CVS or amniocentesis results for common trisomies (Down, Edwards, and Patau syndromes) and microdeletions/microduplications is often recommended. Unfortunately, for many parents, the standard invasive diagnostic test does not check for most genetic syndromes. To check for monogenic syndromes (single gene disorders), someone needs to have a test called exome or whole genome sequencing (WGS). Extended NIPT, looking for selected monogenic syndromes, will have an additional value in those cases. It cannot replace the exome but will screen for common and serious monogenic conditions.
- Reproductive planning: Knowledge of single-gene disorders or microdeletions can inform reproductive decisions, such as choosing between continuing or terminating a pregnancy, planning for specialised care or interventions post-birth, and understanding the likelihood of recurrence in future pregnancies. This information also helps families prepare emotionally and financially for potential medical needs after birth.
Choosing Between Basic and Extended NIPT
While extended NIPT offers a broader scope of screening, it also comes with additional considerations:
- Cost: Extended NIPT is typically more expensive than basic NIPT, which may influence accessibility.
- Time-Consuming: Because of the complexity of the tests, some of the extended NIPTs can have much longer turnaround time.
- False Positives: Screening for microdeletions and sex chromosome aneuploidies may yield higher rates of false positives compared to basic NIPT, necessitating confirmatory diagnostic tests such as amniocentesis or chorionic villus sampling (CVS). Among the various conditions tested, extended NIPT shows the poorest performance for these two categories due to different biological and technical challenges.
- False-Negatives: All NIPTs are screening tests and can have false-negative results due to technological limitations and biological reasons. Many genetic conditions are associated with multiple genes, and these tests are designed to detect only known and relatively common pathogenic mutations, leaving rarer or unknown variants undetected.
- There is a small possibility of identifying a pathogenic single-gene variant (mutation) inherited from a parent. For example, a parent may carry a mild or subclinical form of a genetic disorder without being aware of it. Thorough genetic counselling is essential in such cases to evaluate the potential impact of this variant on the unborn child and to provide tailored advice for the family.
- Counselling Needs: The complexity of results from extended NIPT often requires detailed genetic counselling to help families understand the findings and their implications.
- Only highly advanced genomic laboratories can develop extended NIPT tests capable of detecting monogenic conditions and microdeletions. While these branded extended NIPTs are extensively evaluated and validated internally, they still lack independent validation. It is essential to mention that even basic NIPTs, such as the widely used TDL NIPT in London, have not been validated by external organisations, leaving the actual performance of these tests uncertain.
Genetic Labs and Their Brands of Extended NIPT
Fulgent Genetics (US), an accredited leader in clinical diagnostic genetic sequencing, provides the KNOVA test, which screens for a wide range of single-gene disorders and chromosomal anomalies. KNOVA features a meticulously curated panel of de novo genetic conditions designed to optimise diagnostic performance while minimising false-positive rates. Currently, KNOVA is regarded as one of the best choices for extended NIPT panels in the UK. At London Pregnancy Clinic we offer it as part of out state-of-the-art SMART Test NIPT screening method.
Natera’s (US) Panorama test, which includes screening for microdeletions, and the separate Vistara test, focuses on single-gene disorders. Natera was a pioneer in the development of extended NIPT; however, other companies now offer more comprehensive screening panels. Notably, the Panorama test for 22q11.2 deletion syndrome is the only extended NIPT validated by an independent study, demonstrating a detection rate of approximately 80% and a positive predictive value of about 50%.
Eurofins Genoma (Italy) offers the PrenatalSafe Complete Plus test, which screens for all aneuploidies, microdeletions, and selected monogenic disorders. A unique feature of this test is its ability to screen for cystic fibrosis and its applicability in cases of vanishing twin syndrome. However, PrenatalSafe Complete Plus has a limited monogenic disorders panel, a very long turnaround time, and is relatively expensive.
BGI Genomics (China) features the NIFTY Mono test, specialising in detecting monogenic conditions and other genetic anomalies. Nifty Mono offers probably the most comprehensive panel, screening for hundreds of chromosomal and genetic disorders. However, there are significant concerns regarding the use of patient data by BGI. In 2023, a group of MPs and peers in the UK submitted a letter to the Information Commissioner’s Office, requesting an investigation into privacy concerns surrounding BGI Group, particularly its NIFTY prenatal tests.
BillionToOne (US) offers the UNITY test, which uniquely combines carrier screening with fetal screening. UNITY screens for inherited single-gene disorders such as cystic fibrosis, sickle cell anaemia, and thalassemias, providing detailed insights into both parental and fetal genetic health. Notably, the UNITY and KNOVA panels are complementary, enabling enhanced diagnostic performance when used together.
Final Thoughts.
Choosing between basic and extended NIPT depends on individual circumstances, risk factors, and the level of detail desired in genetic screening. While basic NIPT provides robust detection of common aneuploidies, extended NIPT offers a deeper dive into genetic health by screening for microdeletions and single-gene disorders. It is anticipated that future developments in extended NIPT panels will increasingly focus on screening for monogenic (single-gene) disorders, given their clinical significance and the growing demand for more comprehensive prenatal testing options. Consulting with healthcare professionals and genetic counsellors can help families navigate these choices and ensure the best possible care for both the expectant mother and her baby.
When choosing a clinic for your NIPT, ensure they use advanced high-resolution ultrasound technology for the pre-test scan. High-quality imaging allows for a more accurate assessment of fetal health, which is crucial, particularly in the early stages of pregnancy (10-11 weeks). Avoid clinics with outdated or low-resolution scanners, as this can compromise the accuracy of the scan and potentially impact the performance of your NIPT.
Latest Stories
PCOS Awareness Month
PCOS Awareness Month 2024
Polycystic Ovary Syndrome (PCOS): Understanding, Symptoms, and Care
-
Published
-
Last Modified
Tags
Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting 1 in 10 women in the UK, often leading to fertility challenges and other health risks such as diabetes and cardiovascular disease. This blog explores PCOS symptoms, including irregular periods, weight gain, and excess hair growth, and outlines management options like lifestyle changes, medication, and fertility treatments.
Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder that can have a significant impact on women of reproductive age. Affecting around 1 in 10 women in the UK, PCOS is characterised by a range of symptoms and can lead to complications, including difficulties with fertility. At London Pregnancy Clinic, we are committed to raising awareness about PCOS, its implications, and the support available for managing this condition.
What is Polycystic Ovary Syndrome?
PCOS is a condition that affects the normal functioning of the ovaries due to hormonal imbalances. Typically, it results in irregular or absent periods, and in some cases, multiple small cysts form on the ovaries. The condition often begins during adolescence but can develop at any stage of a woman’s reproductive life. It is important to note that not all women with PCOS will have cysts, despite the name.
It occurs when a woman produces higher-than-normal levels of androgens, or “male hormones,” which disrupt ovulation and other hormonal processes. This imbalance can lead to a variety of symptoms and health challenges, making early detection and management essential.
Polycystic Ovary Syndrome Statistics
PCOS is one of the most common causes of infertility in women, but it often goes undiagnosed. According to the NHS, more than half of women with PCOS do not have any noticeable symptoms, which can delay diagnosis and treatment. In the UK alone, PCOS affects about 10% of women, with its prevalence varying worldwide. The condition not only affects fertility but can also lead to other health issues such as type 2 diabetes, cardiovascular diseases, and mental health problems if left untreated.
Polycystic Ovary Syndrome Symptoms
The symptoms can vary in severity and may develop gradually over time. The most common symptoms include:
- Irregular or absent periods: Due to disrupted ovulation, women with PCOS may experience infrequent or prolonged menstrual cycles.
- Excess hair growth (hirsutism): Elevated levels of androgen hormones can lead to excessive facial and body hair growth.
- Weight gain: Unexplained weight gain or difficulty losing weight is a common symptom, and excess weight can exacerbate the condition.
- Acne and oily skin: The hormonal imbalance often leads to acne, particularly on the face, chest, and back.
- Thinning hair or male-pattern baldness: Hair loss can occur on the scalp due to high androgen levels.
- Ovarian cysts: Although not always present, some women may develop multiple cysts on their ovaries, which can be detected via an ultrasound.
- Difficulty conceiving: As PCOS interferes with ovulation, it is one of the leading causes of infertility in women.
PCOS and Fertility
One of the primary concerns for women with PCOS is infertility. The hormonal imbalance associated with the condition can prevent ovulation, making it difficult for women to conceive. In fact, it is one of the most common causes of infertility worldwide. However, with appropriate medical treatment, many women with PCOS can conceive and have healthy pregnancies.
At London Pregnancy Clinic, we offer a range of fertility treatments, including ovulation induction, hormonal therapy, and assisted reproductive technologies like IVF, to help women with PCOS conceive. Early diagnosis and intervention are key to improving fertility outcomes.
Long-term Health Risks
In addition to reproductive health concerns, PCOS can lead to several long-term health issues. These include:
- Type 2 diabetes: Women are at a higher risk of developing insulin resistance, which can lead to type 2 diabetes.
- Cardiovascular disease: PCOS is associated with an increased risk of high blood pressure, high cholesterol, and heart disease.
- Endometrial cancer: Women may have an increased risk of developing endometrial cancer due to irregular periods and prolonged exposure to oestrogen.
- Mental health issues: Depression, anxiety, and poor body image are common, particularly those struggling with symptoms like infertility and unwanted hair growth.
Managing Polycystic Ovary Syndrome
Although there is no cure for PCOS, the symptoms can be managed effectively through lifestyle changes and medical treatments. At London Pregnancy Clinic, we provide comprehensive care for women with PCOS, focusing on both short-term symptom relief and long-term health management.
- Lifestyle changes: Maintaining a healthy weight through diet and regular exercise can significantly reduce PCOS symptoms. Even a small amount of weight loss can help regulate menstrual cycles and improve insulin sensitivity.
- Medication: Hormonal contraceptives are often prescribed to regulate periods and reduce androgen levels. For women trying to conceive, medications such as Clomiphene can help induce ovulation. Metformin, a medication typically used for type 2 diabetes, can also improve insulin resistance and lower androgen levels.
- Fertility treatments: For women with PCOS struggling to conceive, fertility treatments like IVF may be recommended. Our specialists work closely with patients to develop tailored treatment plans that maximise the chances of a successful pregnancy.
- Cosmetic treatments: Treatments such as laser hair removal or prescription acne medications can help manage the physical symptoms of PCOS, such as excess hair growth and acne.
Raising Awareness About PCOS
The emotional toll of PCOS should not be underestimated. Many women with PCOS struggle with self-esteem, body image issues, and mental health challenges due to symptoms like infertility, weight gain, and hirsutism. At LPC, we offer support for the psychological aspects of PCOS, ensuring women have access to both physical and emotional care.
We are dedicated to raising awareness about PCOS and the importance of early diagnosis and management. PCOS is often underdiagnosed, but with the right care, women can lead healthy lives and achieve their fertility goals. We encourage women who suspect they may have PCOS to seek medical advice and take proactive steps towards managing the condition.
Diagnosing PCOS involves a combination of clinical assessments, blood tests, and imaging studies. During your consultation at London Pregnancy Clinic, your female GP doctor will assess your medical history, perform a physical examination, and conduct blood tests to measure hormone levels. An ultrasound may also be recommended to examine your ovaries for cysts and assess ovulation.
Final Thoughts
Ectopic pregnancy is a serious condition that requires prompt medical attention. Recognising the symptoms early and seeking immediate care can prevent life-threatening complications and preserve future fertility. London Pregnancy Clinic offers advanced early ultrasound services and expert care to detect and manage ectopic pregnancies effectively. If you have concerns about your pregnancy or are experiencing any symptoms of an ectopic pregnancy, contact LPC right away to schedule an early ultrasound and ensure your pregnancy is developing safely.
If you’re concerned about your pregnancy or have experienced any symptoms of an ectopic pregnancy, don’t hesitate to reach out to London Pregnancy Clinic. Early detection is key to managing extrauterine pregnancy effectively. Visit London Pregnancy Clinic for expert advice and care tailored to your needs.
Latest Stories
Ectopic Pregnancy
What is an Ectopic Pregnancy?
Understanding Ectopic Pregnancy: Causes, Symptoms, and Treatment
-
Published
-
Last Modified
Tags
Ectopic pregnancy is a serious and life-threatening condition where a fertilised egg implants outside the uterus. Unlike normal pregnancies, where the embryo develops within the uterine lining, ectopic pregnancies often occur in the fallopian tubes, leading to potentially severe complications. Understanding the signs, causes, and treatment options for extrauterine pregnancy is crucial for early detection and management, which can significantly improve outcomes for women.
In a typical pregnancy, the fertilised egg travels down the fallopian tube and implants itself in the uterus. However, in an ectopic pregnancy, the egg implants outside the uterus, most commonly in the fallopian tube, leading to what is often referred to as a “tubal pregnancy.” Although less common, ectopic pregnancies can also occur in the ovary, abdomen, or cervix. These locations are not equipped to support a growing pregnancy, and as the embryo develops, it can cause severe damage to the surrounding tissues, potentially leading to life-threatening bleeding.
Causes of Ectopic Pregnancy
Several factors can contribute to the likelihood of such a pregnancy. The primary cause is usually damage to the fallopian tubes, which may prevent the fertilised egg from reaching the uterus. Conditions such as pelvic inflammatory disease (PID), often caused by sexually transmitted infections, can inflame and scar the fallopian tubes. Other causes include endometriosis, which leads to abnormal tissue growth outside the uterus, and prior surgeries on the fallopian tubes, which can leave scar tissue that obstructs the egg’s journey. Additionally, hormonal imbalances and certain congenital abnormalities in the fallopian tubes can also increase the risk.
Symptoms of Ectopic Pregnancy
Recognising the symptoms of an ectopic pregnancy is vital for timely intervention. Early symptoms often mimic those of a normal pregnancy, including missed periods, breast tenderness, and nausea. However, the first warning signs of an extrauterine pregnancy are usually pain and vaginal bleeding. Pain can be felt in the pelvis, abdomen, or even the shoulder and neck if the bleeding irritates the diaphragm. This pain can vary from mild and dull to severe and sharp. Other symptoms might include dizziness, fainting, low blood pressure due to blood loss, and lower back pain. If an ectopic pregnancy is not detected early, it can lead to the rupture of the fallopian tube, which is a medical emergency.
Diagnosis of Ectopic Pregnancy
Diagnosing an ectopic pregnancy can be challenging, especially in the early stages when symptoms are similar to a normal pregnancy. If a woman presents with symptoms indicative of an ectopic pregnancy, doctors will typically conduct an ultrasound to determine the location of the pregnancy. However, an ultrasound may not always be able to detect an ectopic pregnancy early on, particularly if it is too small to be seen. In such cases, repeated testing may be necessary. Blood tests for pregnancy that measure human chorionic gonadotropin (hCG) levels are also used, as abnormal levels can indicate a non-intrauterine pregnancy.
Women’s Health Services Beyond Ultrasounds
The treatment for an ectopic pregnancy depends on its size and location, as well as the patient’s overall health. In some cases, if the extrauterine pregnancy is detected early and is small, doctors may use medication such as methotrexate to stop the growth of the embryo. The body then absorbs the tissue naturally. This non-surgical approach is less invasive but requires close monitoring of hCG levels until they return to zero. This can be done with a blood test which London Pregnancy Clinic offers.
For more advanced ectopic pregnancies, surgery is often required. Laparoscopic surgery is the most common method, where the surgeon removes the ectopic pregnancy and repairs any damage to the fallopian tube. In severe cases, where the fallopian tube has ruptured, emergency surgery may be necessary, and the affected fallopian tube might need to be removed. Following treatment, regular follow-up with healthcare providers is essential to ensure complete recovery and monitor future fertility.
Impact on Future Pregnancies
Having an ectopic pregnancy can affect future pregnancies, although many women go on to have normal pregnancies afterward. The risk of a subsequent non-intrauterine pregnancy is higher, especially if the woman has a history of conditions like PID or previous tubal surgeries. However, with proper medical care and monitoring, many women can conceive successfully. It’s important for women who have had an ectopic pregnancy to consult with their doctor before trying to conceive again to discuss the best timing and necessary precautions.
Preventing Ectopic Pregnancy
While it is not always possible to prevent an ectopic pregnancy, certain lifestyle choices can reduce the risk. Quitting smoking is one of the most effective preventive measures, as smoking is linked to damage in the fallopian tubes. Practicing safe sex by using condoms can help prevent sexually transmitted infections, which are a leading cause of PID and, subsequently, ectopic pregnancies. Regular gynecological exams and prompt treatment of infections can also lower the risk.
Emotional Support and Recovery
Experiencing an ectopic pregnancy can be emotionally challenging. It is not uncommon for women to feel a profound sense of loss, similar to that experienced after a miscarriage. Emotional recovery can take time, and many women find it helpful to seek support from counseling services or support groups. It’s important to acknowledge the grief and allow time for healing. Partners and families should also be supportive, understanding that the emotional impact can be significant.
The Importance of Early Ultrasound
Early detection is crucial when it comes to managing ectopic pregnancy effectively. At London Pregnancy Clinic (LPC), we understand the importance of early and accurate diagnosis. Our clinic offers advanced early pregnancy scans that can detect ectopic pregnancies as soon as they develop, often before symptoms become severe. These ultrasounds are essential in confirming the location of the pregnancy, whether it is intrauterine or ectopic. You can read on what to expect at an ultrasound scan on our blog, or watch our youtube video on this.
Ultrasound scans are a crucial part of early pregnancy care and can help ensure that your pregnancy is progressing normally. Here are the key points about when you should consider doing an ultrasound scan, especially in the context of monitoring for ectopic pregnancies:
When to Do an Ultrasound Scan
-
Confirmation of Pregnancy (6-8 Weeks): The first ultrasound is typically done around 6 to 8 weeks of pregnancy. This early scan confirms the pregnancy and helps determine whether the embryo has implanted in the uterus or if there’s a risk of ectopic pregnancy. It also provides information about the viability of the pregnancy, the gestational age, and the number of embryos (in the case of multiple pregnancies).
-
Early Signs of Ectopic Pregnancy: If you experience symptoms that may suggest an ectopic pregnancy, such as pelvic pain, abnormal vaginal bleeding, or shoulder pain, you should have an ultrasound as soon as possible. These symptoms can appear between 4 and 12 weeks of pregnancy. Early detection through ultrasound is crucial in managing ectopic pregnancy before it leads to more serious complications, such as the rupture of the fallopian tube.
-
Uncertain Pregnancy Dates: If your menstrual cycle is irregular or you’re unsure about the date of your last period, an ultrasound scan can help establish the gestational age of the pregnancy. This is important for ensuring that the pregnancy is developing as expected and for scheduling further scans and tests.
-
High-Risk Pregnancies: Women who have a history of ectopic pregnancies, pelvic inflammatory disease (PID), previous tubal surgery, or other risk factors should consider an early ultrasound. This is particularly important if there are any concerning symptoms or if the pregnancy is achieved through fertility treatments, which can increase the risk of ectopic pregnancy.
How LPC Can Help
By scheduling an early ultrasound at LPC, you can ensure that your pregnancy is progressing normally and reduce the risk of complications associated with ectopic pregnancies. Our team of experienced specialists uses the latest ultrasound technology to provide precise and reliable results, giving you peace of mind and the information you need to make informed decisions about your care.
If an ectopic pregnancy is detected, our clinic offers comprehensive support and care, including personalised treatment plans and close monitoring to ensure your safety and well-being. We are committed to providing compassionate care and expert guidance throughout your pregnancy journey.
Final Thoughts
Ectopic pregnancy is a serious condition that requires prompt medical attention. Recognising the symptoms early and seeking immediate care can prevent life-threatening complications and preserve future fertility. London Pregnancy Clinic offers advanced early ultrasound services and expert care to detect and manage ectopic pregnancies effectively. If you have concerns about your pregnancy or are experiencing any symptoms of an ectopic pregnancy, contact LPC right away to schedule an early ultrasound and ensure your pregnancy is developing safely.
If you’re concerned about your pregnancy or have experienced any symptoms of an ectopic pregnancy, don’t hesitate to reach out to London Pregnancy Clinic. Early detection is key to managing extrauterine pregnancy effectively. Visit London Pregnancy Clinic for expert advice and care tailored to your needs.
